Signaling Pathways - Insulin and Insulin-like Receptors - CysLT1 - CREBBP - Vitamin D receptors (VDRs)
清除全部
-
B8031 MK-571 sodium salt hydrate3 CitationTarget: CysLT1Summary: CysLT1受体拮抗剂 -
B2140 Calcifediol中文名: 骨化二醇Target: Vitamin D receptors (VDRs)Summary: 维生素D3的主要循环形式 -
B2091 Doxercalciferol1 Citation中文名: 度骨化醇Target: Vitamin D receptors (VDRs)Summary: 维生素D受体激活剂 -
A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A4491 SGC-CBP302 CitationTarget: CREBBP|EP300Summary: CREBBP/EP300 bromodomain抑制剂 -
A4490 I-CBP 112Target: CREBBP|EP300Summary: CBP/EP300 bromodomain抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂